1
Clinical Trials associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)Tumor Infiltrating Lymphocytes in Pediatric Malignant Solid Tumors: A Prospective Biobanking Study and Phase I Clinical Trial
Part One of this study will determine the feasibility of creating Tumor-Infiltrating Lymphocyte (TIL) product prospectively from high-risk pediatric solid tumors.
Part Two of this study will determine the safety of TIL therapy with lymphodepleting chemotherapy and post-TIL Interleukin-2 in high-risk pediatric solid tumors
100 Clinical Results associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
100 Translational Medicine associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
100 Patents (Medical) associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)
100 Deals associated with Tumor Infiltrating Lymphocyte Therapy(Johns Hopkins All Children's Hospital)